Key Takeaways:
- Massive Investment in Biomedicine: The Walloon Government, in collaboration with BioWin and the Public Service of Wallonia, launches an €81 million innovation partnership focused on Advanced Therapy Medicinal Products (ATMPs).
- Broad Consortium for Groundbreaking Work: The initiative brings together 26 partners for 12 work packages, aiming to create over 470 direct jobs and 1,200 indirect jobs in five years.
- Strategic Importance for Wallonia: This project positions Wallonia as a key player in the EU biopharmaceuticals industry, leveraging its significant contribution to the sector.
A Bold Step in Biomedical Advancement
In a groundbreaking move, the Walloon Government has approved an €81 million funding for an unprecedented Technological Innovation Partnership (ATMP-PIT) focusing on Advanced Therapy Medicinal Products (ATMPs). Spearheaded by Vice-President of Wallonia and Minister of the Economy, Willy Borsus, this initiative is part of the Walloon Recovery Plan and involves a collaborative effort of BioWin, the health cluster of Wallonia, and the Research and Technology Development Department of the Public service of Wallonia.
The Consortium: Collaboration at its Best
This initiative stands out for its wide-reaching collaboration among 26 partners, encompassing academia, research centers, and businesses of varying sizes. The project, which covers the entire value chain of ATMPs, aims to address scientific research, preclinical and clinical research, and innovative production process design and control.
The Impact on Employment and Research
The ATMP PIT is not just a scientific endeavor; it’s a significant economic booster for Wallonia. It is projected to create more than 470 direct jobs and 1,200 indirect jobs over the next five years. This influx of employment opportunities is a testament to the project’s scale and its potential impact on the region’s economy and research capabilities.
ATMPs: The Future of Medicine
ATMPs represent the cutting edge of modern medicine, offering solutions for previously unmet medical needs. The PIT focuses on cell, gene, exosome, and phage therapies, emphasizing large-scale manufacture suitability. This approach is expected to enhance the technological prowess of Walloon businesses.
Wallonia: A Biopharmaceutical Powerhouse
Wallonia’s commitment to this sector is evident from its impressive statistics in the EU’s biopharmaceuticals industry, where it ranks highly in terms of jobs, exports, and investment in research and development. The ATMP market is expected to grow exponentially, reaching a market value of €80 billion by 2032.
BioWin: The Driving Force
BioWin, the health cluster in Wallonia, plays a pivotal role in this partnership. As a hub for all stakeholders in health, biotech, and medtech research and innovation, BioWin’s mission aligns perfectly with the objectives of the ATMP PIT. The cluster aims to accelerate innovation, meet public health challenges, and develop the region’s health sector ecosystem.
Conclusion: A Visionary Leap for Wallonia
The Walloon Government’s investment in ATMP-PIT is more than just funding; it’s a visionary leap into the future of biomedicine. By fostering collaboration among a wide array of partners and focusing on cutting-edge therapies, this initiative sets the stage for Wallonia to become a leader in the global biopharmaceutical industry.
Source: https://biowin.org/
Sign up to our newsletter & get the most important monthly insights from around the world.
Ready to Amplify Your Brand with Business Today?
Discover the power of sponsored articles and partnerships to reach decision-makers, professionals, and a dynamic audience. Learn more about our advertising opportunities and connect with us today!
Click here to explore our Promotion & Sponsored Articles page.
Are you looking to make an impact? Contact us at [email protected] to get started!
